Coming late 2026 is the 0 Saloon which is much closer to last year’s Saloon concept. This will be the flagship of the Honda ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...

Check out real-world situations relating to the Tesla MODEL Y here, particularly what our experts have to say about them. How do Tesla cars work? It’s a popular ... This concentrates on assembly of ...

And if you can't buy a Ferrari F80, buying the stock might just be your next best option. Here's why. The F80 packs a punch, no matter how you look at it. Whether it's the sharp red paint Ferraris ...

In October, reports emerged from China that Shanghai production of the updated Model Y had been pulled forward to start this month, if initially only in low volumes. Two months have passed and none of ...

Apart from a GvHD approval in Japan, this marks the first time one of Mesoblast’s stem cell therapies has been approved after ... Mesoblast shares vaulted 28% to $2.53 this morning. The stock has ...

whereas the pericellular generation of adenosine and the intracellular transfer of cyclic AMP through membrane gap junctions expose the target cell to two potently inhibitory molecules.

A number of car models won't ring in the new year. The Ford Edge, Toyota Venza and Mini Clubman are just some of the vehicles that won't make it past model year 2024 in U.S. markets. Automakers ...

Tesla has done more than most to bring electric cars into the mainstream for car buyers. The Model Y broadened that mission further by adding an excellent family SUV to the company’s range.

BYD is looking to dominate the electric vehicle market worldwide, and its stock is a lot cheaper than Tesla's. As Elecrek reported yesterday, BYD's car factory in Xi'an, China, just passed 1 ...

Scientists at City of Hope have collared a tricky culprit that helps cancer cells evade CAR T cell therapy. CAR T cell therapy harnesses the immune system to seek out and kill tumor cells.

CAR T cell therapy harnesses the immune system to seek out and kill tumor cells. This treatment is used in certain types of leukemia and lymphoma -; blood cancers. Some wily cancer cells ...